CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
CANADA

About Us

Conference

Partner With Us

  • APAC
    • US
    • EUROPE
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    Bioinformatics & Genomics
    BioTech
    Cell and Gene Therapy
    Drug Discovery and Development
    Life Science AI
    Next-Generation Sequencing
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    CDMO
    Cosmetic
    CRO
    Life Science Testing And Compliance
    Supplement Manufacturing
  • Business Services
    Life Science Consulting
    Life Sciences Marketing and Communication
  • Leadership Perspectives
  • Innovation Insights
  • News
  • Magazines
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

A featured contribution from Leadership Perspectives: a curated forum reserved for leaders nominated by our subscribers and vetted by our Life Sciences Review Advisory Board.

MMS Holdings Inc

Jennifer Perrin, Director

From Selection to Training: The Pillars of Successful Quality Outsourcing in Pharma

Jennifer Perrin

Jennifer Perrin

Outsourcing activities in the pharmaceutical industry are common. It helps save on costs like resources, infrastructure, and overhead. When it comes to quality, outsourcing offers similar benefits. Small to mid-sized organizations can get expert guidance to make sure their quality management system (QMS) aligns with their current drug development phase. This helps them improve their QMS as they grow. Larger firms can use outsourcing to bridge any resource gaps or for specialized, short-term quality projects.


However, there are risks in outsourcing quality support. These include ensuring timely and high-quality deliverables, compliance with regulations, maintaining confidentiality, and lack of flexibility. To mitigate these risks, it’s crucial to set clear expectations with quality consultants before the project starts. It’s vital to note that even when outsourcing, the license holder remains responsible for their QMS. They will be accountable to any regulatory body, regardless of who manages the quality function. Therefore, organizations should thoroughly vet consultants to ensure they have the needed qualifications and training.


Here are some frequently outsourced quality functions in the pharmaceutical sector:


1. eQMS Administration: Outsourcing can benefit any sized organization that needs expertise in setting up and running the system. Smaller firms often lack in[1]house validation or quality experts for an eQMS setup. Consultants can handle most tasks remotely, from setting up the system to training users.


Outsourcing can benefit any sized organization that needs expertise in setting up and running the system.


2. Document Management: Consultants can oversee this using your eQMS or other platforms like SharePoint®. It’s essential to ensure that electronic signature tools comply with regulations like 21 CFR Part 11.


3. Training: This is crucial to meet pharmaceutical industry regulations. Consultants can help set up training programs, ensuring employees understand regulations, procedures, and processes. They can also offer specialized regulatory training.


4. Batch Record Review: Essential for ensuring drug quality and safety, consultants offer an unbiased view, especially if in-house staff are deeply involved in processes.


5. Validation: Often outsourced, even by larger companies. While some validation activities might require on-site presence, tasks like computer system validation (CSV) can be remote.


6. Auditing: Remote auditing has grown popular recently. While cost[1]effective, the risks and benefits of remote auditing, especially for manufacturing sites and initial vendor qualifications, need consideration.


7. Remediation: External experts can offer fresh perspectives and process improvements.


Outsourcing quality-related functions goes beyond merely signing a contract. While many of these functions can be effectively outsourced, the ultimate responsibility for product quality and regulatory compliance always rests with the organization, whether it’s the sponsor or market authorization holder. This makes it imperative to select highly experienced and qualified consultants. Equally vital is ensuring these consultants undergo company-specific training, with proper documentation and maintenance of this training. This approach not only safeguards regulatory adherence but also leverages the efficiencies and expertise that outsourcing offers, reinforcing it as a sound and effective strategy.


The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.
The Leadership Perspectives forum brings together voices shaping the future of life sciences. It features leaders who are advancing change across the industry through strategic leadership and applied insight.
EDITOR'S CHOICE
  • Willis Towers Watson

    ICON [NASDAQ: ICLR]

    The Significant Increase in Demand for Clinical Research Associates (CRAs)

    Helen Yeardley, Executive Vice President, ICON [NASDAQ: ICLR]

  • Willis Towers Watson

    PacBio [NASDAQ: PACB]

    The Talent - Culture Continuum: How to Manage an Innovation Culture Amid Growth and Change

    Alvin Hom, Head of Global Talent Acquisition, PacBio [NASDAQ: PACB]

  • Willis Towers Watson

    Repligen Corp [NASDAQ: RGEN]

    Gene Therapy-Therapeutic Viral Vectors; Manufacturing, Challenges, and Innovation

    Rachel Legmann, PhD, Senior Director of Technology, Gene Therapy, Repligen Corp

  • Willis Towers Watson

    Ionis Pharmaceuticals [NASDAQ: IONS]

    Bridging the Diversity Divide

    Victoria Sanjurjo, Medical Director, Clinical Development, Ionis Pharmaceuticals, Inc [NASDAQ: IONS]

Life Sciences Review APAC
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review APAC. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreviewapac.com/cxoinsight/from-selection-to-training-the-pillars-of-successful-quality-outsourcing-in-pharma-nwid-1554.html